NCT02361060View on ClinicalTrials.gov

Effects of Neuromuscular Block Reversal With Sugammadex vs Neostigmine on Postoperative Respiratory Outcomes After Major Abdominal Surgery

PHASE4CompletedINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

July 4, 2016

Study Completion Date

July 4, 2016

Conditions

Major Abdominal Surgery

Interventions

DRUG

Neostigmine

40mcg/kg

DRUG

Sugammadex

4mg/kg

DRUG

Atropine

10 mcg/kg

Trial Locations (2)

28006

Anesthesiology Service. Hospital Universitario La Princesa, Madrid

Hospital Universitario de La Princesa, Madrid

All Listed Sponsors

lead

Enrique Alday Muñoz

OTHER

NCT02361060 - Effects of Neuromuscular Block Reversal With Sugammadex vs Neostigmine on Postoperative Respiratory Outcomes After Major Abdominal Surgery | Biotech Hunter | Biotech Hunter